Court Rejects Two Moderna Defenses in mRNA Vaccine Patent Row With Arbutus

By /

Arbutus alleges that Moderna’s COVID-19 vaccine infringes on patents protecting its lipid nanoparticle delivery technology.

Scroll to Top